Browsing Tag
Boston
63 posts
Why Lilly’s $3.25bn Kelonia acquisition signals a manufacturing shift across the entire CAR-T landscape
Eli Lilly agrees to acquire Kelonia Therapeutics for up to $7B. What the iGPS in vivo CAR-T platform means for oncology and LLY investors. Read the analysis.
NHS England commits £237m to expand Community Diagnostic Centres as government targets record diagnostic output in 2026
The UK government commits £237 million to expand NHS Community Diagnostic Centres across England. What the investment means for waiting lists, care access, and NHS strategy. Read more.
Aramark (NYSE: ARMK) wins Suffolk University dining deal as campus hospitality becomes a growth lever
Aramark’s Suffolk University win is more than a campus dining deal. Read how it could shape growth, student experience, and investor sentiment.
Simon Property Group (NYSE: SPG) announces landmark redevelopment of Copley Place to reinforce Boston luxury retail positioning
Simon Property Group Inc. redevelops Copley Place to anchor Boston luxury retail. Find out what this means for SPG and high-end malls.
U.S. declares multi-state emergencies amid widespread snowfall and freezing rain
Power outages, flight cancellations, and emergency declarations sweep across 20 U.S. states as a powerful winter storm paralyzes major cities and services.
Can Thermo Fisher’s new molecular test transform lung transplant care with faster rejection detection?
Discover how Thermo Fisher’s new AI-based MMDx Lung test improves early detection of lung transplant rejection and reshapes transplant diagnostics.
ExQor Technologies moves closer to clinical trials with brain regenerative medicine for Alzheimer’s disease
ExQor Technologies advances toward clinical trials with a brain regenerative platform that could reverse Alzheimer’s damage and transform dementia care.
Enanta (NASDAQ: ENTA) prices $65m offering at $10 per share — Is this a lifeline or a warning sign?
Enanta Pharmaceuticals (NASDAQ: ENTA) raises $65M in stock offering at $10 per share. Explore dilution risks, investor sentiment, and future outlook.
Apartment Investment (NYSE: AIV) shocks Wall Street with $2.23 special dividend — is this just the start of bigger REIT payouts?
Apartment Investment & Management (NYSE: AIV) declares $2.23 special dividend after Boston property sales — find out what it means for REIT investors.
Can Calluna Pharma’s CAL101 finally change the game for idiopathic pulmonary fibrosis patients?
Calluna Pharma begins Phase 2 AURORA trial of CAL101 in idiopathic pulmonary fibrosis, targeting S100A4 for a novel antifibrotic approach.